Company Info

Krystal Biotech

Drug Discovery & Development

Overview

Krystal Biotech, Inc. (NASDAQ:KRYS) is a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases.

Contributions

Contributors

Contributions

1 Contributions1 / 1

Clinical Trials

Krystal Biotech Announces Positive Results from Phase 2 Clinical Trial and Receives Regenerative Medicine Advanced Therapy Designation

Krystal Biotech

PR-M06-19-NI-047Jun 25, 2019

1 / 1

0 Contributors1 / 0

No authors found

1 / 0

Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us Nice Insight That's Nice

Reach Our Team

My Account

Subscribe for the newsletter

Subscribe for the Newsletter

Mobile Navigation

Company Info

Krystal Biotech

Drug Discovery & Development

Overview

Clinical Trials

Krystal Biotech Announces Positive Results from Phase 2 Clinical Trial and Receives Regenerative Medicine Advanced Therapy Designation

Krystal Biotech

No authors found

No authors found

Clinical Trials

Krystal Biotech Announces Positive Results from Phase 2 Clinical Trial and Receives Regenerative Medicine Advanced Therapy Designation

Krystal Biotech